We are live on
!
Find out more
LMR Partners Portfolio holdings
AUM
$26.8B
Turnover
48.2%
1-Year Est. Return
68.38%
This Fund
S&P 500
This Quarter
Est. Return
+6.21%
1 Year Est. Return
+68.38%
3 Year Est. Return
+229.41%
5 Year Est. Return
+267.31%
10 Year Est. Return
+749.57%
AUM
$45.4B
AUM Growth
-$7.71B
(-15%)
Cap. Flow
-$1.43B
Cap. Flow
% of AUM
-3.15%
Top 10 Holdings %
Top 10 Hldgs %
59.32%
Holding
1,978
New
488
Increased
294
Reduced
243
Closed
561
Avg Time Held Equity + Options
0.6
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.6
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$191M |
| 2 |
Penumbra
PEN
|
+$100M |
| 3 |
Motorola Solutions
MSI
|
+$86.6M |
| 4 |
Eli Lilly
LLY
|
+$83.6M |
| 5 |
Tesla
TSLA
|
+$81.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$161M |
| 2 |
NVIDIA
NVDA
|
+$144M |
| 3 |
CyberArk
CYBR
|
+$138M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$136M |
| 5 |
AstraZeneca
AZN
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 86.33% |
| 2 | Technology | 4.15% |
| 3 | Healthcare | 1.9% |
| 4 | Financials | 1.88% |
| 5 | Communication Services | 1.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
PUT
Sarepta Therapeutics
SRPT
$1.81B
| $31M | 0.07% |
1,422,800
-30,000
| -2% | -$581K |
2025 Q3
2 quarters
|
|
127
Amprius Technologies Warrants
AMPX.WS
$228M
| $30.8M | 0.07% |
4,489,842
+151,069
| +3% | +$790K |
2024 Q4
5 quarters
|
|
128
CALL
DELISTED
Electronic Arts
EA
| $30.6M | 0.07% |
150,000
+148,900
| +13,536% | +$30.1M |
2025 Q1
4 quarters
|
|
129
DigitalOcean
DOCN
$11.6B
| $30.5M | 0.07% |
355,951
-264,049
| -43% | -$16.6M |
2025 Q4
1 quarter
|
|
130
DELISTED
Qorvo
QRVO
| $30.5M | 0.07% |
393,660
+103,501
| +36% | +$8.38M |
2024 Q3
6 quarters
|
|
131
CALL
Boston Scientific
BSX
$64.3B
| $30.4M | 0.07% |
484,800
+98,700
| +26% | +$7.9M |
2025 Q2
3 quarters
|
|
132
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$49.8B
| $30.3M | 0.07% |
350,000
-2,172,200
| -86% | -$191M |
2025 Q1
4 quarters
|
|
133
PUT
Regeneron Pharmaceuticals
REGN
$81.4B
| $30.1M | 0.07% |
39,000
+34,000
| +680% | +$26M |
2025 Q2
3 quarters
|
|
134
Sandisk
SNDK
$188B
| $30M | 0.07% |
47,158
-153,858
| -77% | -$86.9M |
2025 Q3
2 quarters
|
|
135
Repligen
RGEN
$11.1B
| $29.8M | 0.07% |
+253,060
| New | +$35.4M |
2026 Q1
0 quarters
|
|
136
CALL
ImmunityBio
IBRX
$9.73B
| $29.3M | 0.06% |
+3,824,900
| New | +$26.2M |
2026 Q1
0 quarters
|
|
137
Uniti Group
UNIT
$1.36B
| $29.3M | 0.06% |
3,123,700
+653,700
| +26% | +$5.12M |
2024 Q4
5 quarters
|
|
138
PUT
Bilibili
BILI
$5.8B
| $29.3M | 0.06% |
1,297,100
| – | – |
2025 Q2
3 quarters
|
|
139
Lumentum
LITE
$74.7B
| $28.9M | 0.06% |
41,190
-68,084
| -62% | -$37.4M |
2025 Q2
3 quarters
|
|
140
PUT
Biogen
BIIB
$34.4B
| $28.3M | 0.06% |
+154,300
| New | +$28.4M |
2026 Q1
0 quarters
|
|
141
Intel
INTC
$475B
| $28.2M | 0.06% |
640,017
-147,395
| -19% | -$6.76M |
2024 Q3
6 quarters
|
|
142
Circle Internet Group
CRCL
$20.9B
| $27.9M | 0.06% |
+292,842
| New | +$24.8M |
2026 Q1
0 quarters
|
|
143
Elanco Animal Health
ELAN
$11.8B
| $27.9M | 0.06% |
+1,165,358
| New | +$28.5M |
2026 Q1
0 quarters
|
|
144
CALL
NextEra Energy
NEE
$166B
| $27.9M | 0.06% |
300,000
+178,100
| +146% | +$15.8M |
2024 Q4
5 quarters
|
|
145
SPDR Gold Trust
GLD
$141B
| $27.2M | 0.06% |
63,309
+38,059
| +151% | +$17M |
2025 Q1
4 quarters
|
|
146
CALL
Coinbase
COIN
$45.7B
| $27.1M | 0.06% |
155,000
-103,900
| -40% | -$20.5M |
2024 Q4
5 quarters
|
|
147
CALL
DELISTED
Terns Pharmaceuticals
TERN
| $27M | 0.06% |
+512,400
| New | +$21M |
2026 Q1
0 quarters
|
|
148
Applied Materials
AMAT
$325B
| $26.8M | 0.06% |
78,550
+43,547
| +124% | +$14.6M |
2024 Q3
6 quarters
|
|
149
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.54B
| $25.5M | 0.06% |
200,000
-300,000
| -60% | -$37.5M |
2025 Q4
1 quarter
|
|
150
CALL
ConocoPhillips
COP
$176B
| $25.4M | 0.06% |
+192,300
| New | +$21.3M |
2026 Q1
0 quarters
|
|
Similar funds
LMR Partners's Q1 2026 Portfolio in Review
As of Q1 2026, LMR Partners held 1,978 positions worth $45.4B, down 15% from $53.1B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
LMR Partners withdrew a net $1.43B in Q1 2026, closing 561 positions and reducing 243 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 89% a quarter earlier, followed by Technology and Healthcare.
Against the trend, LMR Partners opened a new position in Penumbra worth $97.1M.
- LMR Partners's largest Q1 2026 buy was Penumbra: 295,708 shares worth $97.1M.
- LMR Partners added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $191M increase.
- LMR Partners's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $144M.
- LMR Partners fully exited iShares National Muni Bond ETF in Q1 2026, selling an estimated $161M.
- LMR Partners's ten largest holdings make up 59% of its $45.4B portfolio in Q1 2026.
- LMR Partners opened 488 new positions and closed 561 in Q1 2026.
- LMR Partners's portfolio value fell 15% quarter-over-quarter to $45.4B.
Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.